As of 2025-03-16, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -11.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 539.78 mil USD. TMCI's TTM EBITDA according to its financial statements is -46.95 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 21.2x | 18.8x |
| Forward P/E multiples | 21.0x - 24.0x | 22.6x |
| Fair Price | (16.40) - (16.59) | (16.15) |
| Upside | -306.3% - -308.7% | -303.2% |
| Date | EV/EBITDA |
| 2025-03-14 | -11.50 |
| 2025-03-13 | -11.48 |
| 2025-03-12 | -11.81 |
| 2025-03-11 | -11.95 |
| 2025-03-10 | -11.87 |
| 2025-03-07 | -12.33 |
| 2025-03-06 | -12.53 |
| 2025-03-05 | -13.07 |
| 2025-03-04 | -12.69 |
| 2025-03-03 | -12.58 |
| 2025-02-28 | -12.82 |
| 2025-02-27 | -13.07 |
| 2025-02-26 | -13.83 |
| 2025-02-25 | -13.71 |
| 2025-02-24 | -13.69 |
| 2025-02-21 | -13.39 |
| 2025-02-20 | -13.78 |
| 2025-02-19 | -14.30 |
| 2025-02-18 | -14.54 |
| 2025-02-14 | -14.34 |
| 2025-02-13 | -14.34 |
| 2025-02-12 | -13.99 |
| 2025-02-11 | -14.23 |
| 2025-02-10 | -14.54 |
| 2025-02-07 | -14.57 |
| 2025-02-06 | -14.61 |
| 2025-02-05 | -14.95 |
| 2025-02-04 | -14.91 |
| 2025-02-03 | -13.82 |
| 2025-01-31 | -14.30 |
| 2025-01-30 | -14.27 |
| 2025-01-29 | -14.79 |
| 2025-01-28 | -13.51 |
| 2025-01-27 | -13.83 |
| 2025-01-24 | -13.19 |
| 2025-01-23 | -13.38 |
| 2025-01-22 | -13.47 |
| 2025-01-21 | -13.26 |
| 2025-01-17 | -12.51 |
| 2025-01-16 | -11.90 |
| 2025-01-15 | -12.19 |
| 2025-01-14 | -11.58 |
| 2025-01-13 | -12.05 |
| 2025-01-10 | -10.63 |
| 2025-01-08 | -10.99 |
| 2025-01-07 | -11.10 |
| 2025-01-06 | -11.28 |
| 2025-01-03 | -11.43 |
| 2025-01-02 | -11.39 |
| 2024-12-31 | -10.82 |